In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors

Journal of Controlled Release : Official Journal of the Controlled Release Society
Joanna M KoziaraRussell J Mumper

Abstract

Colloidal carriers have been shown to improve tumor therapy by increased drug delivery into tumor sites resulting directly from the enhanced permeability and retention effect (EPR). However, the clinical outcome of tumor therapy is often limited due to multidrug resistance. Several different types of resistance exist with expression of p-glycoprotein being the most commonly described. Paclitaxel entrapped in emulsifying wax nanoparticles (PX NPs) was shown to overcome drug resistance in a human colon adenocarcinoma cell line (HCT-15). In the present studies, the in-vivo efficacy of PX NPs in a HCT-15 mouse xenograft model was demonstrated. Significant inhibition in tumor growth was observed in mice receiving PX NPs treatment. Additionally, mice dosed with Taxol also demonstrated slower tumor growth; however, the efficacy of the Taxol treatment was shown in the in-vitro HUVEC model to be due to the antiangiogenic effect of paclitaxel. It was concluded that the enhanced efficacy of PX NPs over Taxol in the xenograft model was due to both overcoming paclitaxel resistance and an antiangiogenic effect.

References

Jan 1, 1994·Cancer Chemotherapy and Pharmacology·A Colin de VerdièreP Couvreur
Dec 1, 1995·Journal of Pharmaceutical Sciences·A SharmaR J Bernacki
Dec 1, 1996·Japanese Journal of Cancer Research : Gann·M TomonagaS Kohno
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·D A BerkR K Jain
Aug 1, 1997·Japanese Journal of Cancer Research : Gann·M OkaS Kohno
Mar 17, 2001·Advanced Drug Delivery Reviews·J Kreuter
Jun 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·S C KimM H Seo
Aug 16, 2001·Journal of the National Cancer Institute·M R VredenburgR J Bernacki
May 25, 2002·Drug Development and Industrial Pharmacy·Moses O Oyewumi, Russell J Mumper
Oct 3, 2002·Japanese Journal of Cancer Research : Gann·Hideki EnokidaMasayuki Nakagawa
Oct 5, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cristina FonsecaRogério Gaspar
Nov 6, 2002·The Journal of Clinical Investigation·Stephan FellnerGert Fricker
Jan 10, 2003·Journal of Liposome Research·David SadavaSusan E Kane
Jan 16, 2003·International Journal of Pharmaceutics·Moses O Oyewumi, Russell J Mumper
Jan 18, 2003·International Journal of Cancer. Journal International Du Cancer·Derrick S GrantAdam P Dicker
Jul 2, 2003·Nature Biotechnology·Tadanori YamadaShun'ichi Kuroda
Dec 10, 2003·Pharmaceutical Research·Joanna M KoziaraRussell J Mumper
Feb 18, 2004·Current Medicinal Chemistry·Si-Shen FengGuofeng Huang
Mar 17, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Moses O OyewumiRussell J Mumper
Sep 8, 2004·International Journal of Cancer. Journal International Du Cancer·Sanjeeb K SahooVinod Labhasetwar
Sep 24, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Joanna M KoziaraRussell J Mumper
Sep 30, 2004·International Journal of Cancer. Journal International Du Cancer·Jaime R MerchanVikas P Sukhatme
Mar 15, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Eun Seong LeeYou Han Bae
Jun 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alex SparreboomNeil Desai

❮ Previous
Next ❯

Citations

Feb 8, 2013·Angiogenesis·Guido BocciRomano Danesi
Aug 21, 2013·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·G R Rivera-RodríguezD Torres
May 9, 2013·International Journal of Pharmaceutics·Zhengyuan ZhouDavid Attwood
Dec 22, 2009·Chemical Communications : Chem Comm·Benjamin ThierryPeter Majewski
Dec 7, 2007·Journal of Occupational Medicine and Toxicology·Sarabjeet Singh SuriBaljit Singh
Aug 29, 2012·International Journal of Nanomedicine·Nasimudeen R JabirMohammad A Kamal
Apr 27, 2013·International Journal of Nanomedicine·Yanzuo ChenXiaoling Fang
Jun 10, 2010·Nanomedicine·Xiaowei Dong, Russell J Mumper
Jan 11, 2014·Molecular Pharmaceutics·Huiyuan WangYongzhuo Huang
Sep 21, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ruth HemmerKristi L Haik
Jul 12, 2014·Drug Delivery·Prabhjot KaurAmit K Goyal
Dec 3, 2014·Biotechnology Advances·Shengpeng WangMeiwan Chen
Feb 19, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Alina ShapiraYehuda G Assaraf
Jan 11, 2011·Nanomedicine : Nanotechnology, Biology, and Medicine·Srikanth KakumanuRobert J Nicolosi
Oct 23, 2010·Advanced Drug Delivery Reviews·Sarbari Acharya, Sanjeeb K Sahoo
Sep 15, 2009·International Journal of Pharmaceutics·Sudhir S ChakravarthiDennis H Robinson
Jun 6, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Daniel MorenoMaría J Garrido
Dec 30, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Xiaowei DongRussell J Mumper
Sep 18, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Ayman KhdairJayanth Panyam
Oct 1, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Medha D Joshi, Rainer H Müller
Nov 21, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Myung Soo KimElena V Batrakova
Sep 28, 2007·Journal of Biomedical Materials Research. Part a·Zhiyuan HuYangde Zhang
Nov 3, 2010·The Journal of Pharmacy and Pharmacology·Heike Bunjes
Mar 23, 2007·Chemico-biological Interactions·Julia Y LjubimovaEggehard Holler
Nov 23, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Emmanuel A HoMicheline Piquette-Miller
Apr 2, 2016·Proceedings of the National Academy of Sciences of the United States of America·Ashish KulkarniShiladitya Sengupta
Nov 20, 2013·Trends in Biotechnology·Hirak K Patra, Anthony P F Turner
Sep 4, 2015·Future Medicinal Chemistry·Jae Hyon MoonHonggang Cui
Sep 17, 2013·Advanced Drug Delivery Reviews·Ameya R KirtaneJayanth Panyam
Jun 23, 2012·International Journal of Pharmaceutics·Krassimira YonchevaJuan M Irache
Jan 27, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Priyanka BhatnagarKailash C Gupta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.